trending Market Intelligence /marketintelligence/en/news-insights/trending/d-Ef0WyYYlArgNw4CyHDGQ2 content esgSubNav
In This List

Esperion Therapeutics appoints director

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


Esperion Therapeutics appoints director

Esperion Therapeutics Inc. appointed Jeffrey Berkowitz as a class 2 director of the company.

Berkowitz's term expires at the Ann Arbor, Mich.-based company's 2018 annual shareholders meeting.

He was previously an executive vice president of Optum Inc., UnitedHealth Group Inc.'s health services platform business.